Literature DB >> 14607908

Modulation of O-glycans and N-glycans on murine CD8 T cells fails to alter annexin V ligand induction by galectin 1.

Douglas A Carlow1, Michael J Williams, Hermann J Ziltener.   

Abstract

Thymic negative selection and contraction of responding T cell oligoclones after infection represent important cell ablation processes required for maintaining T cell homeostasis. It has been proposed that galectin 1 contributes to these processes through interaction with lactosyl sequences principally on cell surface glycoproteins bearing core 2 (C2GnT1)-branched O-glycans. According to this model, specific T cell surface proteins cross-linked by galectin 1 induce signaling, ligand redistribution, and apoptosis in both immature thymocytes and activated T cells. The influence of lactosyl residues contained in branched O-glycans or complex N-glycans on galectin 1 binding and induction of annexin V ligand in murine CD8 T cells was assessed. Neither galectin binding nor galectin-induced expression of annexin V ligand was perturbed under conditions in which: 1) C2GnT1 activity was differentially induced by CD8 T cell activation/culture with IL-2 vs IL-4; 2) activated CD8(+) T cells lacked C2GnT1 expression; or 3) complex N-glycan formation was blocked by swainsonine. The maintenance of galectin 1 binding and induced annexin V expression under conditions that alter lactosamine abundance on O- or complex N-glycans suggest that galectin 1-mediated apoptosis is neither a simple function of fluctuating C2GnT1 activity nor a general C2GnT1-dependent mechanism underlying contraction of CD8 T cells subsequent to activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607908     DOI: 10.4049/jimmunol.171.10.5100

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells.

Authors:  Sean R Stowell; Sougata Karmakar; Caleb J Stowell; Marcelo Dias-Baruffi; Rodger P McEver; Richard D Cummings
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

2.  Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.

Authors:  M Frank Erasmus; Ksenia Matlawska-Wasowska; Ichiko Kinjyo; Avanika Mahajan; Stuart S Winter; Li Xu; Michael Horowitz; Diane S Lidke; Bridget S Wilson
Journal:  Sci Signal       Date:  2016-11-29       Impact factor: 8.192

3.  Galectin-3 initiates epithelial-stromal paracrine signaling to shape the proteolytic microenvironment during corneal repair.

Authors:  Dina B AbuSamra; Jérôme Mauris; Pablo Argüeso
Journal:  Sci Signal       Date:  2019-07-16       Impact factor: 8.192

4.  Novel fluorescent glycan microarray strategy reveals ligands for galectins.

Authors:  Xuezheng Song; Baoyun Xia; Sean R Stowell; Yi Lasanajak; David F Smith; Richard D Cummings
Journal:  Chem Biol       Date:  2009-01-30

5.  Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation.

Authors:  Sean R Stowell; Moonjae Cho; Christa L Feasley; Connie M Arthur; Xuezheng Song; Jennifer K Colucci; Sougata Karmakar; Padmaja Mehta; Marcelo Dias-Baruffi; Rodger P McEver; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

6.  Galectin-1 signaling in leukocytes requires expression of complex-type N-glycans.

Authors:  Sougata Karmakar; Sean R Stowell; Richard D Cummings; Rodger P McEver
Journal:  Glycobiology       Date:  2008-07-16       Impact factor: 4.313

7.  Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane.

Authors:  Sean R Stowell; Sougata Karmakar; Connie M Arthur; Tongzhong Ju; Lilian C Rodrigues; Thalita B Riul; Marcelo Dias-Baruffi; Jonathan Miner; Rodger P McEver; Richard D Cummings
Journal:  Mol Biol Cell       Date:  2008-12-30       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.